Douglas Johnson

Professor of medicine and director of the Melanoma Clinical Research Program at Vanderbilt Ingram Cancer Center in Nashville, Tennessee. Co-leads research initiatives focused on therapeutic biomarkers and strategies to overcome treatment resistance in melanoma.

Best podcasts with Douglas Johnson

Ranked by the Snipd community

Jun 2, 2025 • 54min

S13 Ep8: Oncology PER® Spectives: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

Rahul A. Sheth, an expert in interventional oncology, Yana Najjar, a leading medical oncologist, and Douglas Johnson, a melanoma research director, dive into cutting-edge melanoma treatments. They discuss the role of oncolytic viruses in overcoming immune checkpoint resistance and share insights from the IGNITE trial. The importance of interdisciplinary collaboration between medical oncologists and interventional radiologists in administering these therapies is highlighted. They also touch on safety, workflow challenges, and the promise of innovative combination therapies for advanced cases.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app